French biotech Abivax's shares climb on Eli Lilly bid rumors

Core Viewpoint - Shares of French biotech company Abivax increased by 20% due to market speculation regarding a potential bid from U.S. pharmaceutical giant Eli Lilly [1] Company Summary - Abivax is a French biotech firm experiencing a significant rise in share price, attributed to rumors of interest from Eli Lilly [1] Industry Summary - The news highlights the potential for mergers and acquisitions within the biotech sector, particularly involving established pharmaceutical companies like Eli Lilly [1]